The assays to come, are spread across different areas, so this has posed a problem for the Ampella Management. They are trying to get a more systematic and prioritized assaying, but I understand this is a little problematical for the Lab Mngt. Ampella has given samples to the lab as fast as they come from the different rigs working in different areas. So the lab is working a lot like this, which is not optimal for making sense of.
Above this, there are indigestion problems caused by the number of other companies presenting significant numbers of assays to the labs in Burkina. This is affecting all companies as I understand it.
I would rather have the results released in a systematic fashion rather than spasmodic, because it is too hard to read.
AMX Price at posting:
48.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)